معرفی
Qian Yu is a Research Fellow in the Department of Internal Medicine at Yale University's Yale School of Medicine. Their research focuses on cellular and molecular mechanisms underlying lung injury, inflammatory responses, and therapeutic interventions for respiratory diseases. Key areas include vascular integrity in acute lung injury, pharmacological modulation of inflammation, and drug development targeting lung pathologies. Yu's work also explores lipid transport pathways and WNT signaling in skeletal and metabolic disorders. Their studies integrate experimental models with clinical applications, particularly in evaluating novel compounds for treating lung injuries and cancer.
Research interests span cell biology, immunology, and pharmacology, with emphasis on translational medicine. Yu has contributed to understanding ferroptosis in viral lung damage, MAP kinase pathway inhibition in lung injury, and exocytosis mechanisms in cerebral cavernous malformations. Their publications highlight innovations in drug repurposing (e.g., pazopanib for coronavirus treatments) and molecular mechanisms of disease progression.
Yu's academic contributions include over 30 peer-reviewed articles, with recent focus on small molecule therapies, extracellular vesicle signaling, and genomic analysis of gliomas. While no awards are explicitly listed, their research has implications for developing new treatments for acute lung injury, cancer, and neurovascular disorders. No advising or grant information is provided in the current profile.
